A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal–Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes

被引：0

作者：

Sultan Linjawi

Byung-Wan Lee

Ömür Tabak

Susanna Lövdahl

Shanti Werther

Salahedeen Abusnana

机构：

[1] Coffs Endocrine and Diabetes Service,Division of Endocrinology and Metabolism, Department of Internal Medicine

[2] Yonsei University College of Medicine,Internal Medicine Clinic

[3] Ministry of Health Istanbul Kanuni Sultan Suleyman Training and Research Hospital,undefined

[4] Novo Nordisk A/S,undefined

[5] Rashid Center for Diabetes and Research,undefined

来源：

Diabetes Therapy | 2018年 / 9卷

关键词：

Basal–bolus; BIAsp 30; Stepwise insulin intensification; Type 2 diabetes;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1 / 11

页数：10

共 50 条

[1] A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal-Bolus Therapy in Insulin-Naive Patients with Type 2 Diabetes
Linjawi, Sultan
Lee, Byung-Wan
Tabak, A-mur
Lovdahl, Susanna
Werther, Shanti
Abusnana, Salahedeen
DIABETES THERAPY, 2018, 9 (01) : 1 - 11
[2] Use of a New Basal Insulin with a Bolus Boost (IDegAsp) in Type 2 Diabetes: Comparison with Biphasic Insulin Aspart 30 (BIAsp 30)
Vaag, Allan
Leiter, Lawrence A.
Franek, Edward
Weng, Jianping
Damci, Taner
Munoz Torres, Manuel
Donnet, Jean-Paul
Endahl, Lars
Skjoth, Trine V.
Niskanen, Leo
DIABETES, 2011, 60 : A313 - A313
[3] Stepwise intensification of prandial insulin versus basal-bolus insulin therapy in patients with type 2 diabetes mellitus
Raccah, D.
Haak, T.
Huet, D.
Monnier, L.
Ramon, J. S.
Robertson, D.
Labard, P.
Penfornis, A.
DIABETOLOGIA, 2010, 53
[4] Similar glucose control with basal bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients with type 2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification
Malek, R.
Ajili, F.
Assaad-Khalil, S. H.
Shinde, A.
Chen, J. W.
Van den Berg, E.
DIABETES & METABOLISM, 2015, 41 (03) : 223 - 230
[5] Similar gulcose control with basal-bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients wiwth type 2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification
Baminger, H.
AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2015, 8 (03): : 87 - 88
[6] Biphasic Insulin Aspart 30 (BIAsp 30) is Safe and Improves Glycaemic Control in Insulin Naive Patients with Type 2 Diabetes
Esteghamati, Alireza
Nakhjavani, Manouchehr
Aminorroaya, Ashraf
Aboutorabi, Robabeh
Niafar, Mitra
Mohammadi, Mohammad
Parvaresh, Ehsan
JOURNAL OF DIABETES & METABOLISM, 2011, 2 (03)
[7] Similar glucose control with basal-bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients with type-2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification Experts Commentary
Wascher, Thomas
AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2015, 8 (03): : 88 - 88
[8] Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
Valensi, Paul
DIABETES METABOLIC SYNDROME AND OBESITY, 2009, 2 : 61 - 71
[9] Insulin Degludec/Insulin Aspart (IDegAsp) Twice Daily (BID) vs. Biphasic Insulin Aspart 30 (BIAsp 30) BID-A Randomized Trial in Chinese Patients with Type 2 Diabetes
Yang, Wenying
Ma, Jianhua
Hong, Tianpei
Liu, Ming
Miao, Heng
Peng, Yongde
Wang, Changjiang
Xu, Xiangjin
Yang, Tao
Nielsen, Anne Moeller
Pan, Lili
Liu, Weihong
Zhao Weigang
DIABETES, 2018, 67
[10] Multiple mealtime administration of biphasic insulin aspart 30 versus traditional basal-bolus human insulin treatment in patients with type 1 diabetes
Chen, J. -W.
Lauritzen, T.
Bojesen, A.
Christiansen, J. S.
DIABETES OBESITY & METABOLISM, 2006, 8 (06): : 682 - 689

← 1 2 3 4 5 →